Search research articles
Contact Us
Filters
Showing results (241-250 of 296) with videos related to
Page
of 30
Sort By:
Frontiers in Immunology
|
March 18, 2021
Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India
Prasad D Taur, Vijaya Gowri, Ambreen Abdulwahab Pandrowala, et al.
Journal of Clinical Immunology
|
August 31, 2022
Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico
Ana Karen Peñafiel Vicuña, Marco Yamazaki Nakashimada, Ximena León Lara, et al.
Blood
|
July 7, 2017
Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic <i>IKBKG</i>/NEMO mutations
Charline Miot, Kohsuke Imai, Chihaya Imai, et al.
The Journal of Experimental Medicine
|
July 13, 2016
Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets
Cindy S Ma, Natalie Wong, Geetha Rao, et al.
The Journal of Clinical Investigation
|
October 8, 2021
Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents
Romain Lévy, David Langlais, Vivien Béziat, et al.
The Journal of Experimental Medicine
|
July 2, 2008
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells
Ludovic de Beaucoudrey, Anne Puel, Orchidée Filipe-Santos, et al.
Gastroenterology
|
June 23, 2026
BIRC3 (Encoding Cellular Inhibitor of Apoptosis Protein 2) Variants Result in Dysregulated Receptor-Interacting Protein Kinase 1 Signaling Leading to Increased Epithelial Cell Death and Are Associated With Monogenic Crohn's Disease
Qi Li, Ryusuke Nambu, Hu Yaqiang, et al.
The Journal of Experimental Medicine
|
February 5, 2021
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
Paul Bastard, Eleftherios Michailidis, Hans-Heinrich Hoffmann, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts
Adrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity
|
March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts
Adrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 296) with videos related to
Sort By:
Page
of 30
Frontiers in Immunology
|
March 18, 2021
Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India
Prasad D Taur, Vijaya Gowri, Ambreen Abdulwahab Pandrowala, et al.
Journal of Clinical Immunology
|
August 31, 2022
Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico
Ana Karen Peñafiel Vicuña, Marco Yamazaki Nakashimada, Ximena León Lara, et al.
Blood
|
July 7, 2017
Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic <i>IKBKG</i>/NEMO mutations
Charline Miot, Kohsuke Imai, Chihaya Imai, et al.
The Journal of Experimental Medicine
|
July 13, 2016
Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets
Cindy S Ma, Natalie Wong, Geetha Rao, et al.
The Journal of Clinical Investigation
|
October 8, 2021
Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents
Romain Lévy, David Langlais, Vivien Béziat, et al.
The Journal of Experimental Medicine
|
July 2, 2008
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells
Ludovic de Beaucoudrey, Anne Puel, Orchidée Filipe-Santos, et al.
Gastroenterology
|
June 23, 2026
BIRC3 (Encoding Cellular Inhibitor of Apoptosis Protein 2) Variants Result in Dysregulated Receptor-Interacting Protein Kinase 1 Signaling Leading to Increased Epithelial Cell Death and Are Associated With Monogenic Crohn's Disease
Qi Li, Ryusuke Nambu, Hu Yaqiang, et al.
The Journal of Experimental Medicine
|
February 5, 2021
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
Paul Bastard, Eleftherios Michailidis, Hans-Heinrich Hoffmann, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts
Adrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity
|
March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts
Adrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Page
of 30